Owner Odyssey Pharmaceuticals, Inc.

Inventors Galarneau, Andre; Michnick, Stephen W.

Agent King & Wood Mallesons

Pub. Number AU-A-2012203377

Parent 2008201746

Filing date 8 June 2012

Wipo publication date 5 July 2012

G01N 33/53 Investigating or analysing materials by specific methods not covered by groups - Immunoassay

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 9/78 Enzymes, e.g. ligases (6.) - acting on carbon to nitrogen bonds other than peptide bonds (3.5)

C12N 15/09 Mutation or genetic engineering - Recombinant DNA-technology

C12Q 1/02 Measuring or testing processes involving enzymes or micro-organisms - involving viable micro-organisms

C12Q 1/34 Measuring or testing processes involving enzymes or micro-organisms - involving hydrolase

G01N 21/78 Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible, or ultra-violet light

G01N 33/50 Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

G01N 33/531 Investigating or analysing materials by specific methods not covered by groups - Production of immunochemical test materials

G01N 33/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent